Bilal, Muhammad
El Tabei, Lobna
Büsker, Sören
Krauss, Christian
Fuhr, Uwe
Taubert, Max http://orcid.org/0000-0001-8925-7782
Funding for this research was provided by:
Universität zu Köln
Article History
Accepted: 26 July 2021
First Online: 22 August 2021
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL. This work was based on internal funding of the Department I of Pharmacology, University of Cologne, Cologne, Germany.
: Muhammad Bilal, Lobna El Tabei, Sören Büsker, Christian Krauss, and Uwe Fuhr declare no conflict of interest. Max Taubert is an employee of Novartis AG.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors screened articles and abstracts for inclusion, discussed results and conclusions, and wrote the manuscript. MT and UF supervised the review process.